New 1-(2-chloroquinolin-3-yl)-4-dimethylamino-2-(naphthalen-1-yl)-1-phenylbutan-2-ols with antituberculosis activity


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

New 4-dimethylamino-2-(naphthalen-1-yl)-1-phenyl-1-(quinolin-3-yl)butan-2-ols with antituberculosis activity were synthesized. (1R*,2S*)-1-(6-Bromo-2-chloroquinolin-3-yl)-4-dimethylamino-2-(naphthalen-1-yl)-1-phenylbutan-2-ol hydrocitrate exhibiting high antituberculosis activity is in the final stage of clinical trials and is prepared for use in clinical practice.

Sobre autores

A. Omel’kov

Pharm-Sintez

Autor responsável pela correspondência
Email: omelkov@mail.ru
Rússia, Build. 134, 29 ul. Vereyskaya, Moscow, 121357

V. Fedorov

Pharm-Sintez

Email: omelkov@mail.ru
Rússia, Build. 134, 29 ul. Vereyskaya, Moscow, 121357

A. Stepanov

Pharm-Sintez

Email: omelkov@mail.ru
Rússia, Build. 134, 29 ul. Vereyskaya, Moscow, 121357

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Springer Science+Business Media, LLC, part of Springer Nature, 2019